WuXi Biologics Announces First Integrated CRDMO Center in Middle East
WuXi Biologics has announced a strategic partnership with the Qatar Free Zones Authority to establish its first integrated CRDMO center in the Middle East. This expansion aims to leverage Qatar's healthcare ecosystem and logistics infrastructure to drive biopharmaceutical innovation and support the growth of Qatar's biotechnology sector.
WuXi Biologics (Cayman) Inc., a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has announced a strategic partnership with the Qatar Free Zones Authority (QFZ) to expand its global network into the Middle East. The agreement paves the way for WuXi Biologics to establish its first integrated CRDMO center in the region, leveraging Qatar’s advanced healthcare ecosystem and strong logistics infrastructure. This expansion aims to drive biopharmaceutical innovation and support the growth of Qatar’s biotechnology sector, positioning the country as a hub for future biopharmaceutical advancements. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics (Cayman) Inc. published the original content used to generate this news brief on December 02, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
